Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept

Nutrition

Volumn 23, Issue 11-12, 2007, Pages 844-852

  Kornman, Kenneth ^a   Rogus, John ^a   Roh Schmidt, Haeri ^b   Krempin, David ^b   Davies, Audra J ^b   Grann, Kerry ^b   Randolph, R Keith ^b  

^a Interleukin Genetics   (United States)

^b Nutrilite   (United States)

Author keywords

Botanical; C reactive protein; Genotype; Interleukin 1; Nutrigenetics; Rose hips

Indexed keywords

ANTHOCYANIN; C REACTIVE PROTEIN; DEHYDROASCORBIC ACID; GRAPEVINE EXTRACT; INTERLEUKIN 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PLACEBO; PLANT EXTRACT; RESVERATROL; ROSE HIP EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLACKBERRY; BLUEBERRY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENE OVEREXPRESSION; GENETIC VARIABILITY; GENOTYPE; GRAPE JUICE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; NORMAL HUMAN; NUTRIGENETICS; NUTRITION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VOLUNTEER;

ADULT; ANTI-INFLAMMATORY AGENTS; C-REACTIVE PROTEIN; CELLS, CULTURED; FEMALE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MONOCYTES; NUTRIGENOMICS; PLANT EXTRACTS; PROSPECTIVE STUDIES; ROSA; VARIATION (GENETICS);

RUBUS; VACCINIUM; VITIS;

EID: 34948867271     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.08.005     Document Type: Article

References (36)

1. Dziedzic T. Systemic inflammatory markers and risk of dementia. Am J Alzheimers Dis Other Demen 21 (2006) 258-262
2. Ravaglia G, Forti P, Maioli F, Chiappelli M, Montesi F, Tumini E, et al. Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging. Neurobiol Aging 2006. doi: 10.1016/j.neurobiolaging. 2006.08.012
3. Heneka M.T., and O'Banion M.K. Inflammatory processes in Alzheimer's disease. J Neuroimmunol 189 (2007) 69-81
4. Kornman K.S. Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr 83 suppl (2006) 475S-83
5. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83 suppl (2006) 456S-60
6. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
7. Kirii H., Niwa T., Yamada Y., Wada H., Saito K., Iwakura Y., et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23 (2003) 656-660
8. Nicklin M.J., Barton J.L., Nguyen M., FitzGerald M.G., Duff G.W., and Kornman K. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79 (2002) 718-725
9. Isoda K., Sawada S., Ishigami N., Matsuki T., Miyazaki K., Kusuhara M., et al. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 24 (2004) 1068-1073
10. Chen H., Wilkins L.M., Aziz N., Cannings C., Wyllie D.H., Bingle C., et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15 (2006) 519-529
11. Iacoviello L., Di Castelnuovo A., Gattone M., Pezzini A., Assanelli D., Lorenzet R., et al. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 25 (2005) 222-227
12. di Giovine F.S., Camp N., Cox A., Chaudhary A., Crane A., and Duff G. Detection and population analysis of IL-1 and TNF gene polymorphisms in cytokine molecular biology (2000), Oxford University Press, Oxford
13. Berger P., McConnell J.P., Nunn M., Kornman K.S., Sorrell J., Stephenson K., et al. C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 17 (2002) 171-174
14. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
15. Merhi-Soussi F., Kwak B.R., Magne D., Chadjichristos C., Berti M., Pelli G., et al. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res 66 (2005) 583-593
16. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86 (2006) 515-581
17. Kusuhara M., Isoda K., and Ohsuzu F. Interleukin-1 and occlusive arterial diseases. Cardiovasc Hematol Agents Med Chem 4 (2006) 229-235
18. Nicklin M.J., Hughes D.E., Barton J.L., Ure J.M., and Duff G.W. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 191 (2000) 303-312
19. Shepherd J., and Nicklin M.J. Elastic-vessel arteritis in interleukin-1 receptor antagonist deficient mice involves effector Th1 cells and requires interleukin-1 receptor. Circulation 111 (2005) 3135-3140
20. Kornman K.S., Martha P.M., and Duff G.W. Genetic variations and inflammation: a practical nutrigenomics opportunity. Nutrition 20 (2004) 44-49
21. Hernandez-Guerrero C., Monzon-Bordonaba F., Jimenez-Zamudio L., Ahued-Ahued R., Arechavaleta-Velasco F., Strauss III J.F., et al. In-vitro secretion of proinflammatory cytokines by human amniochorion carrying hyper-responsive gene polymorphisms of tumour necrosis factor-alpha and interleukin-1beta. Mol Hum Reprod 9 (2003) 625-629
22. Lopez N.J., Jara L., and Valenzuela C.Y. Association of interleukin-1 polymorphisms with periodontal disease. J Periodontol 76 (2005) 234-243
23. Camargo M.C., Mera R., Correa P., Peek Jr. R.M., Fontham E.T., Goodman K.J., et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15 (2006) 1674-1687
24. Wang P., Xia H.H., Zhang J.Y., Dai L.P., Xu X.Q., and Wang K.J. Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer 120 (2007) 552-562
25. Yucesoy B., Peila R., White L.R., Wu K.M., Johnson V.J., Kashon M.L., et al. Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study. Neurobiol Aging 27 (2006) 211-217
26. Rainero I., Bo M., Ferrero M., Valfre W., Vaula G., and Pinessi L. Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis. Neurobiol Aging 25 (2004) 1293-1298
27. Tai E.S., Corella D., Demissie S., Cupples L.A., Coltell O., Schaefer E.J., et al. Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J Nutr 135 (2005) 397-403
28. Dwyer J.H., Allayee H., Dwyer K.M., Fan J., Wu H., Mar R., et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350 (2004) 29-37
29. Hakonarson H., Thorvaldsson S., Helgadottir A., Gudbjartsson D., Zink F., Andresdottir M., et al. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. JAMA 293 (2005) 2245-2256
30. McCombs R.J., Marcadis D.E., Ellis J., and Weinberg R.B. Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med 331 (1994) 706-710
31. Paradis A.M., Fontaine-Bisson B., Bosse Y., Robitaille J., Lemieux S., Jacques H., et al. The peroxisome proliferator-activated receptor alpha Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men. Am J Clin Nutr 81 (2005) 523-530
32. Muller M., and Kersten S. Nutrigenomics: goals and strategies. Nat Rev Genet 4 (2003) 315-322
33. Meydani S.N., Endres S., Woods M.M., Goldin B.R., Soo C., Morrill-Labrode A., et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 121 (1991) 547-555
34. Wu D., Han S.N., Meydani M., and Meydani S.N. Effect of concomitant consumption of fish oil and vitamin E on production of inflammatory cytokines in healthy elderly humans. Ann N Y Acad Sci 1031 (2004) 422-424
35. Botsios C. Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases. Autoimmun Rev 4 (2005) 162-170
36. Ridker P.M. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 92 suppl 4B (2003) 17K-22K